Trials / Completed
CompletedNCT02941900
Interest and Impact of Skin Cancer Genetic Testing
PERSONALIZED GENOMIC TESTING FOR MELANOMA: MAXIMIZING COMPREHENSION AND HEALTH OUTCOMES IN SKIN CANCER PATIENTS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 53 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to learn whether the patient might be interested in skin cancer genetic testing, and if so, what kinds of thoughts, feelings, and behaviors might result from this testing. Testing for skin cancer risk based on the MC1R gene is not currently used in clinical practice; it will be offered in this study for research purposes only.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | MC1R genotyping | |
| BEHAVIORAL | MC1R Testing Website | The website includes three educational modules about genetic testing with corresponding knowledge questions. |
| BEHAVIORAL | Baseline Survey |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2023-01-18
- Completion
- 2023-01-18
- First posted
- 2016-10-21
- Last updated
- 2023-01-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02941900. Inclusion in this directory is not an endorsement.